The Board of Directors and the President of Emotra AB hereby present the interim report for the third quarter of 2021.... Interim report jan - sept 2021
Emotra AB (publ) Interim report 1 January – 30 September, 2021
read more
INVESTORS
Emotra announces the exercise price for subscription warrants in the TO 2 series
On November 25, 2021, Emotra AB (“Emotra” or “the Company”) established the exercise price for... 211126 - Emotra- PR - Emotra, exercise price for subscription warrants in TO2 series
Emotra AB: Emotra finalizes its acquisition of NeuraMetrix
As announced on August 31, 2021, Emotra AB (publ) has agreed to acquire all outstanding shares in NeuraMetrix Inc... 211126 - Emotra- PR - Emotra finalizes its acquisition of NeuraMetrix
Emotra AB announces that an executive, a board member, and the company’s largest shareholder intend to exercise their subscription warrants
Emotra AB (“Emotra” or “the Company”) announce that its President, Daniel Poté, the chairman of the board, Claes Holmberg... 211125- Emotra - PR - Emotra insiders intend to exercise subscription warrants in TO2 2021 series
EMOTRA AB: Our dispute with an Italian supplier has finally been resolved
Emotra is happy to announce that a dispute with an Italian supplier that has been ongoing since 2017 has finally been resolved. 211125 - Emotra- PR - Dispute with Italian supplier finally resolved
Daniel Rudeklint appointed CFO of Emotra AB
Emotra AB has employed Daniel Rudeklint as its CFO. Daniel brings his experience from auditing and internal auditing... 211115 - Emotra- PM - Daniel Rudeklint appointed CFO
Emotra AB (publ) announces that the publication of their interim report for the period Jan–Sep 2021 has been postponed to November 29
Today, October 27, 2021, the board of Emotra AB (publ) decided to postpone the publication... 211027 - Emotra - PM - Publication of interim report postponed to November 29
EMOTRA AB: A candidate for the board of directors has notified us that he is presently not available for appointment
Emotra has been informed by a candidate for new director... 211007 - PM - Emotra notifies that candidate for board is no longer available for appointment to the board of NeuraMetrix AB
Emotra is granted patent protection in Canada
EDOR test, Emotra’s method for identifying at-risk populations in mental health care, has now secured increased protection... 210707 - Emotra- PM - Emotra is granted patent protection in Canada
Emotra signs agreement with King’s College London, UK
An agreement for collaboration has been signed between Kings College in the UK and Emotra. z 210709 - Emotra - PM - Emotra signs agreement with Kings College